Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Seagen Inc.
Seagen Inc.
Hoffmann-La Roche
M.D. Anderson Cancer Center
Endeavor Biomedicines, Inc.
M.D. Anderson Cancer Center
Replimune Inc.
OHSU Knight Cancer Institute
MacroGenics
DualityBio Inc.
Daiichi Sankyo
ImmunityBio, Inc.
City of Hope Medical Center
Therakos LLC
Mayo Clinic
Incyte Corporation
Mayo Clinic
Bayer
University of Pittsburgh
Tempus AI
Institut Bergonié
Day One Biopharmaceuticals, Inc.
EuroCityClinic LLC
Yale University
Oslo University Hospital
Iovance Biotherapeutics, Inc.
Merck Sharp & Dohme LLC
Incyte Corporation
Seagen Inc.
Vall d'Hebron Institute of Oncology
Innovent Biologics (Suzhou) Co. Ltd.
Dana-Farber Cancer Institute
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ImaginAb, Inc.
Centre hospitalier de l'Université de Montréal (CHUM)
Exelixis
Memorial Sloan Kettering Cancer Center
N.N. Petrov National Medical Research Center of Oncology
University Hospital, Ghent
The Methodist Hospital Research Institute
Hoffmann-La Roche
Incyte Corporation
Jules Bordet Institute
Istituto Clinico Humanitas
Duke University
TC Biopharm
National Institutes of Health Clinical Center (CC)
Yale University
DEKK-TEC, Inc.
MultiVir, Inc.